Order results by:
Issue | Title | |
Vol 17, No 1 (2025) | Aggressive multiple sclerosis in the Republic of Bashkortostan | Abstract similar documents |
K. Z. Bakhtiyarova, U. Sh. Kuzmina, O. V. Lyutov, I. D. Talipova, N. F. Akhmetgaleeva, T. R. Galiullin, M. A. Kutlubaev | ||
"... Treatment of patients with aggressive multiple sclerosis (MS) characterized by severe progression ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical and epidemiological characteristics of multiple sclerosis in students in the Republic of Bashkortostan | Abstract similar documents |
A. V. Tukhvatullin, U. Sh. Kuzmina, N. F. Utyagulova, R. F. Talisov, V. A. Vakhitov, K. Z. Bakhtiyarova | ||
"... An expansion of the age range of multiple sclerosis (MS) manifestation has been reported recently ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Parent-child relationship and family system characteristics in families of adolescents with multiple sclerosis | Abstract similar documents |
E. A. Boyko, E. V. Ivanchuk, K. R. Latii, V. L. Malygin, O. V. Bykova, T. T. Batysheva | ||
"... The incidence of multiple sclerosis (MS) is increasing in all age groups, including children ..." | ||
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
"... Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating and neurodegenerative ..." | ||
Vol 15 (2023): (Suppl. 1) | Features of multiple sclerosis in childhood in the Republic of Tatarstan | Abstract similar documents |
A. R. Khaibullina, F. A. Khabirov, T. I. Khaibullin | ||
"... Multiple sclerosis (MS) in children and adolescents is a genuine concern of pediatric neurology ..." | ||
Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
"... . Objective: to determine the efficacy and safety of cladribine in the treatment of multiple sclerosis (MS ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents | Abstract similar documents |
M. D. Bogdanova, T. T. Batysheva, Yu. V. Mikadze, R. Ts. Bembeeva, E. Yu. Volkova | ||
"... Pediatric-onset multiple sclerosis (MS) can lead to cognitive impairment (CI). In general ..." | ||
Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
"... The involvement of the visual pathway in multiple sclerosis (MS) pathology determines ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Microbiota markers level in the cerebrospinal fluid of patients with multiple sclerosis and radiologically isolated syndrome | Abstract similar documents |
A. N. Boyko, M. V. Melnikov, O. V. Boyko, A. R. Kabaeva, M. A. Omarova, O. G. Zhilenkova, A. M. Zatevalov, V. S. Rogovskii | ||
"... According to numerous studies, gut microbiota plays a significant role in multiple sclerosis (MS ..." | ||
Vol 8, No 3 (2016) | Cardiointervalography in patients with multiple sclerosis | Abstract similar documents |
A. R. Rakhmatullin, K. Z. Bakhtiyarova, R. V. Magzhanov | ||
"... Cardiovascular autonomic symptoms significantly impart quality of life in patients with multiple ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Informative value of neuropsychological tests for multiple sclerosis | Abstract similar documents |
A. R. Kabaeva, A. N. Boyko | ||
"... Cognitive impairment (CI) occurs in 43–70% of patients with multiple sclerosis (MS) at both early ..." | ||
Vol 7, No 1 (2015) | Time course of changes in the development of gait disorders in multiple sclerosis | Abstract similar documents |
A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova | ||
"... Objective: to estimate the time course of changes in foot biomechanical function as multiple ..." | ||
Vol 17, No 4 (2025) | Hyperhomocysteinemia and endothelial dysfunction in multiple sclerosis | Abstract similar documents |
E. A. Dubchenko, A. N. Boyko, A. V. Ivanov, M. A. Popov, R. A. Maslennikov, M. P. Kruglova, E. V. Silina, E. I. Gusev, A. A. Kubatiev | ||
"... For a comprehensive study of such a socially significant disease as multiple sclerosis (MS), which ..." | ||
Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
"... Multiple sclerosis (MS) is an autoimmune inflammatory neurodegenerative disease of the central ..." | ||
Vol 17, No 1 (2025) | Contribution of genomic variation to the severity of multiple sclerosis | Abstract similar documents |
O. G. Kulakova, N. A. Matveeva, I. S. Kiselev, A. N. Boyko, O. O. Favorova | ||
"... Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system of polygenic ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis | Abstract similar documents |
Ya. V. Vlasov, N. G. Polyarnaya, A. N. Boyko | ||
"... Management of patients with secondary progressive multiple sclerosis (SPMS) remains one ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Polymorphic variants in the PVT1 locus affect multiple sclerosis severity | Abstract PDF (Eng) similar documents |
I. S. Kiselev, M. S. Kozin, N. M. Baulina, G. V. Pavlova, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
"... Multiple sclerosis (MS) is a chronic autoimmune disease, in the pathogenesis of which ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Analytical epidemiology of multiple sclerosis in the Republic of Kabardino-Balkaria | Abstract similar documents |
L. B. Tlapshokova, A. R. Zikhova | ||
"... Multiple sclerosis (MS) is a common autoimmune disease, which etiology includes a complex ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Genome-wide polygenic analysis of multiple sclerosis markers | Abstract similar documents |
Ya. R. Timasheva, T. R. Nasibullin, I. A. Tuktarova, V. V. Erdman, T. R. Galiullin, O. V. Zaplakhova, K. Z. Bakhtiiarova | ||
"... Objective: to perform a genome-wide polygenic analysis of multiple sclerosis (MS) markers ..." | ||
Vol 16 (2024): (Suppl. 2) | Combined analysis of free kappa chains and central vein sign increases the specificity of multiple sclerosis diagnosis | Abstract similar documents |
Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
"... ) in the diagnosis of multiple sclerosis (MS). Material and methods. Eighty patients participated in the study ..." | ||
Vol 8, No 4 (2016) | USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS | Abstract similar documents |
V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev | ||
"... dimethyl fumarate in the treatment of multiple sclerosis (MS) in European countries. A pharmacoeconomic ..." | ||
Vol 16, No 2 (2024) | The central vein sign in the diagnosis of multiple sclerosis | Abstract similar documents |
Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, O. N. Voskresenskaya | ||
"... ) for the diagnosis of multiple sclerosis (MS). Material and methods. We analyzed 76 patients. The main group ..." | ||
Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
"... One of the promising areas in the pathogenetic treatment of multiple sclerosis (MS) is anti-B-cell ..." | ||
Vol 11, No 3 (2019) | Mitochondrial genome and risk of multiple sclerosis | Abstract similar documents |
A. N. Boyko, M. S. Kozin, G. Zh. Osmak, O. G. Kulakova, O. O. Favorova | ||
"... risk of multiple sclerosis (MS). Objective: to analyze the frequency of mtDNA variants in patients ..." | ||
Vol 7, No 1 (2015) | Non-biological complex drugs and their analogues in the pathogenetic therapy of multiple sclerosis: Issues of efficacy and safety in clinical use | Abstract similar documents |
I. D. Stolyarov, A. M. Petrov, M. V. Votintseva, I. G. Nikiforova | ||
"... of multiple sclerosis (MS) – glatiramer acetate (GA, Copaxone®, Teva) in large Russian MS centers ..." | ||
Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
"... Once the symptoms of multiple sclerosis (MS) occur, the risk of developing epilepsy within 5 years ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
"... for multiple sclerosis (MS) in the presence of persistent herpesvirus infection (PHVI) remain poorly understood ..." | ||
Vol 15, No 6 (2023) | Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” (October 1, 2023). Main conclusions of the first meeting | Abstract similar documents |
A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha | ||
"... of patients with multiple sclerosis” on the organization of medical care, diagnosis and treatment of multiple ..." | ||
Vol 16 (2024): (Suppl. 2) | Global transcriptome profiling of blood mononuclear cells from individuals with radiologically isolated syndrome reveals abnormalities characteristic of the rapid manifestation of multiple sclerosis symptoms | Abstract similar documents |
M. S. Kozin, A. R. Kabaeva, M. A. Omarova, A. N. Boyko, O. O. Favorova, O. G. Kulakova | ||
"... of a group of patients with radiologically isolated syndrome (RIS) who developed symptoms of multiple ..." | ||
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Reduced expression of the tumor necrosis factor gene in blood mononuclear cells in radiologically isolated syndrome – validation of transcriptome analysis results | Abstract similar documents |
M. S. Kozin, N. M. Baulina, I. S. Kiselev, A. R. Kabaeva, A. N. Boyko, O. O. Favorova, O. G. Kulakova | ||
"... (MRI) reveals lesions of the white matter of the brain and/or spinal cord characteristic of multiple ..." | ||
Vol 10, No 3 (2018) | Balo's concentric sclerosis: a clinical case | Abstract PDF (Eng) similar documents |
I. V. Litvinenko, G. N. Bisaga, V. S. Chirsky, R. F. Gimadutdinov, P. S. Dynin, S. Yu. Golokhvastov, V. Yu. Lobzin | ||
"... of the central nervous system (CNS), which is currently classified as multiple sclerosis. In recent years ..." | ||
Vol 16, No 3 (2024) | Concentration of immunoglobulin free light chains in cerebrospinal fluid in the diagnosis of multiple sclerosis | Abstract PDF (Eng) similar documents |
Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
"... of multiple sclerosis (MS). Material and methods. 80 patients participated in the study. The main group ..." | ||
Vol 14, No 2 (2022) | Changes in expression of miRNAs from the DLK1-DIO3 locus are characteristic of relapsing-remitting multiple sclerosis regardless of the disease activity | Abstract similar documents |
N. M. Baulina, A. R. Kabaeva, A. N. Boyko, O. O. Favorova | ||
"... The role of miRNAs – small, regulatory, noncoding RNAs – in the multiple sclerosis (MS ..." | ||
Vol 17, No 4 (2025) | The role of noradrenaline in regulating the interaction between CD14+ monocytes and CD4+ T cells in multiple sclerosis | Abstract similar documents |
D. V. Nikolaeva, R. R. Zhetishev, A. V. Lopatina, A. A. Sviridova, D. D. Esipova, N. E. Murugina, V. V. Murugin, A. N. Boiko, M. V. Melnikov | ||
"... Multiple sclerosis (MS) is an autoimmune demyelinating and neurodegenerative disease ..." | ||
Vol 7, No 3 (2015) | Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis | Abstract similar documents |
V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev | ||
"... drugs in the treatment of multiple sclerosis through cost, cost-effectiveness, and budget impact ..." | ||
Vol 17, No 4 (2025) | The role of central vein sign in differential diagnostics of neuromyelitis optica spectrum disorders and multiple sclerosis | Abstract similar documents |
S. V. Kotov, E. S. Novikova, G. T. Tonya, A. S. Kotov | ||
"... spectrum disorders (NMOSD) and multiple sclerosis (MS). The presence of central vein sign (CVS) in areas ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The combined effect of nuclear and mitochondrial genomes on the risk of developing multiple sclerosis | Abstract PDF (Eng) similar documents |
M. S. Kozin, I. S. Kiselev, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
"... Multiple sclerosis (MS) is a severe chronic CNS disease characterized by autoimmune inflammation ..." | ||
Vol 15, No 6 (2023) | MRI assessment of different types of chronic demyelinating lesions in patients with multiple sclerosis using quantitative susceptibility mapping (QSM) | Abstract similar documents |
M. S. Matrosova, V. V. Bryukhov, E. V. Popova, G. N. Belskaya, M. V. Krotenkova | ||
"... Histologically, chronic demyelinating lesions in multiple sclerosis (MS) have been shown ..." | ||
Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
"... Objective: to study the pyramidal tract in patients with highly active multiple sclerosis (HAMS ..." | ||
Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
"... Multiple sclerosis (MS) is an autoimmune-inflammatory and neurodegenerative disease of the central ..." | ||
Vol 15 (2023): (Suppl. 1) | Delayed diagnosis of the neuromyelitis optica spectrum disorder | Abstract similar documents |
S. A. Dzhukkaeva, E. V. Ermilova, Sh. R. Nabiev, O. N. Voskresenskaya | ||
Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
"... multiple sclerosis (RRMS) in remission. Material and methods. 38 patients with RRMS were analyzed (33 women ..." | ||
Vol 17, No 2 (2025) | Multitarget transcranial magnetic theta-burst stimulation in the correction of cognitive impairment in patients with progressive multiple sclerosis | Abstract PDF (Eng) similar documents |
A. Kh. Zabirova, I. S. Bakulin, A. G. Poydasheva, D. Yu. Lagoda, M. N. Zakharova, E. V. Gnedovskaya, N. A. Suponeva, M. A. Piradov | ||
"... Cognitive impairment (CI) is a common symptom in multiple sclerosis (MS) that significantly ..." | ||
Vol 16, No 3 (2024) | Optic neuritis in various demyelinating diseases | Abstract PDF (Eng) similar documents |
A. K. Kalashnikova, D. D. Eliseeva, N. A. Andreeva, N. V. Zhorzholadze, I. A. Ronzina, R. Ts. Bembeeva, N. N. Venediktova, M. R. Kalganova, N. L. Sheremet | ||
"... glycoprotein (MOG) confirmed the existence of two disease entities distinct from multiple sclerosis (MS ..." | ||
1 - 44 of 44 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)